Adaptin Bio (APTN) Invested Capital (2022 - 2026)

Adaptin Bio has disclosed Invested Capital across 4 years of filings, most recently posting -$1.5 million for Q2 2026.

• In Q2 2026, Invested Capital changed N/A year-over-year to -$1.5 million; the TTM figure through Jun 2026 stood at -$1.5 million (changed N/A YoY), while the FY2024 annual figure was -$2.3 million, down 182.96% from the prior year.
• Invested Capital came in at -$1.5 million for Q2 2026 at Adaptin Bio, up from -$1.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$22000.0 in Q4 2022 to a low of -$3.1 million in Q3 2024.
• Average Invested Capital over 4 years is -$1.4 million, with a median of -$1.5 million recorded in 2026.
• The largest YoY upside for Invested Capital was 182.96% in 2024 against a maximum downside of 8238.8% in 2024.
• Over 4 years, Invested Capital stood at -$22000.0 in 2022, then plunged by 3605.1% to -$815121.0 in 2023, then sank by 182.96% to -$2.3 million in 2024, then surged by 34.83% to -$1.5 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were -$1.5 million in Q2 2026, -$1.5 million in Q1 2026, and -$2.3 million in Q4 2024.